Madhucon Projects Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 27, 2025, 12:46 pm

Quick Insight

Madhucon Projects Ltd, operating in the Construction, Contracting, and Engineering sector, currently presents a challenging financial picture with a low Price-to-Book Value of -0.04x and an Intrinsic Value of 6.46. The company's negative Net Profit of -523 Cr. and Operating Profit Margin of -23% raise concerns about its profitability and operational efficiency. Additionally, Madhucon's high level of borrowings at ₹3,554 Cr. and low Interest Coverage Ratio of 0.05x indicate potential financial stress. Despite a respectable Return on Capital Employed of 27.6%, the company's negative Reserves of -1,475 Cr. suggest a need for capital infusion or strategic restructuring to stabilize its financial position and improve investor confidence.

Competitors of Madhucon Projects Ltd

All Competitor Stocks of Madhucon Projects Ltd

Quarterly Result

Last Updated: August 20, 2025, 7:30 am

Below is a detailed analysis of the quarterly data for Madhucon Projects Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 157.00 Cr.. The value appears strong and on an upward trend. It has increased from 139.00 Cr. (Mar 2025) to 157.00 Cr., marking an increase of 18.00 Cr..
• For Expenses, as of Jun 2025, the value is 194.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 175.00 Cr. (Mar 2025) to 194.00 Cr., marking an increase of 19.00 Cr..
• For Operating Profit, as of Jun 2025, the value is -36.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded -36.00 Cr..
• For OPM %, as of Jun 2025, the value is -23.00%. The value appears strong and on an upward trend. It has increased from -26.00% (Mar 2025) to -23.00%, marking an increase of 3.00%.
• For Other Income, as of Jun 2025, the value is 47.00 Cr.. The value appears strong and on an upward trend. It has increased from 37.00 Cr. (Mar 2025) to 47.00 Cr., marking an increase of 10.00 Cr..
• For Interest, as of Jun 2025, the value is 6.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 27.00 Cr. (Mar 2025) to 6.00 Cr., marking a decrease of 21.00 Cr..
• For Depreciation, as of Jun 2025, the value is 131.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 26.00 Cr. (Mar 2025) to 131.00 Cr., marking an increase of 105.00 Cr..
• For Profit before tax, as of Jun 2025, the value is -127.00 Cr.. The value appears to be declining and may need further review. It has decreased from -52.00 Cr. (Mar 2025) to -127.00 Cr., marking a decrease of 75.00 Cr..
• For Tax %, as of Jun 2025, the value is 0.00%. The value appears to be improving (decreasing) as expected. It has decreased from 18.00% (Mar 2025) to 0.00%, marking a decrease of 18.00%.
• For Net Profit, as of Jun 2025, the value is -127.00 Cr.. The value appears to be declining and may need further review. It has decreased from -61.00 Cr. (Mar 2025) to -127.00 Cr., marking a decrease of 66.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is -15.97. The value appears to be declining and may need further review. It has decreased from -5.27 (Mar 2025) to -15.97, marking a decrease of 10.70.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 4:53 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: June 16, 2025, 11:46 am

Below is a detailed analysis of the balance sheet data for Madhucon Projects Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 7.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 7.00 Cr..
• For Reserves, as of Mar 2025, the value is -1,475.00 Cr.. The value appears to be improving (becoming less negative). It has improved from -1,510.00 Cr. (Mar 2024) to -1,475.00 Cr., marking an improvement of 35.00 Cr..
• For Borrowings, as of Mar 2025, the value is 3,554.00 Cr.. The value appears to be improving (decreasing). However, Reserves are negative, which is a major warning sign. It has decreased from 3,913.00 Cr. (Mar 2024) to 3,554.00 Cr., marking a decrease of 359.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 1,526.00 Cr.. The value appears to be improving (decreasing). It has decreased from 1,802.00 Cr. (Mar 2024) to 1,526.00 Cr., marking a decrease of 276.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 3,612.00 Cr.. The value appears to be improving (decreasing). It has decreased from 4,213.00 Cr. (Mar 2024) to 3,612.00 Cr., marking a decrease of 601.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 124.00 Cr.. The value appears to be declining and may need further review. It has decreased from 169.00 Cr. (Mar 2024) to 124.00 Cr., marking a decrease of 45.00 Cr..
• For CWIP, as of Mar 2025, the value is 87.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 87.00 Cr..
• For Investments, as of Mar 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 1.00 Cr..
• For Other Assets, as of Mar 2025, the value is 3,400.00 Cr.. The value appears to be declining and may need further review. It has decreased from 3,956.00 Cr. (Mar 2024) to 3,400.00 Cr., marking a decrease of 556.00 Cr..
• For Total Assets, as of Mar 2025, the value is 3,612.00 Cr.. The value appears to be declining and may need further review. It has decreased from 4,213.00 Cr. (Mar 2024) to 3,612.00 Cr., marking a decrease of 601.00 Cr..

However, the Borrowings (3,554.00 Cr.) are higher than the Reserves (-1,475.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Key Financial Ratios

After reviewing the key financial ratios for Madhucon Projects Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 24, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 1.00.
• For Basic EPS (Rs.), as of Mar 24, the value is -6.11. This value is below the healthy minimum of 5. It has increased from -19.47 (Mar 23) to -6.11, marking an increase of 13.36.
• For Diluted EPS (Rs.), as of Mar 24, the value is -6.11. This value is below the healthy minimum of 5. It has increased from -19.47 (Mar 23) to -6.11, marking an increase of 13.36.
• For Cash EPS (Rs.), as of Mar 24, the value is -3.91. This value is below the healthy minimum of 3. It has decreased from 83.99 (Mar 23) to -3.91, marking a decrease of 87.90.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is -268.52. It has increased from -318.40 (Mar 23) to -268.52, marking an increase of 49.88.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is -268.52. It has increased from -318.40 (Mar 23) to -268.52, marking an increase of 49.88.
• For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 157.20. It has increased from 157.00 (Mar 23) to 157.20, marking an increase of 0.20.
• For PBDIT / Share (Rs.), as of Mar 24, the value is 0.32. This value is below the healthy minimum of 2. It has decreased from 87.65 (Mar 23) to 0.32, marking a decrease of 87.33.
• For PBIT / Share (Rs.), as of Mar 24, the value is -3.98. This value is below the healthy minimum of 0. It has increased from -20.26 (Mar 23) to -3.98, marking an increase of 16.28.
• For PBT / Share (Rs.), as of Mar 24, the value is -9.57. This value is below the healthy minimum of 0. It has increased from -26.63 (Mar 23) to -9.57, marking an increase of 17.06.
• For Net Profit / Share (Rs.), as of Mar 24, the value is -8.21. This value is below the healthy minimum of 2. It has increased from -23.93 (Mar 23) to -8.21, marking an increase of 15.72.
• For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is -6.09. This value is below the healthy minimum of 2. It has increased from -19.41 (Mar 23) to -6.09, marking an increase of 13.32.
• For PBDIT Margin (%), as of Mar 24, the value is 0.20. This value is below the healthy minimum of 10. It has decreased from 55.83 (Mar 23) to 0.20, marking a decrease of 55.63.
• For PBIT Margin (%), as of Mar 24, the value is -2.52. This value is below the healthy minimum of 10. It has increased from -12.90 (Mar 23) to -2.52, marking an increase of 10.38.
• For PBT Margin (%), as of Mar 24, the value is -6.08. This value is below the healthy minimum of 10. It has increased from -16.96 (Mar 23) to -6.08, marking an increase of 10.88.
• For Net Profit Margin (%), as of Mar 24, the value is -5.22. This value is below the healthy minimum of 5. It has increased from -15.24 (Mar 23) to -5.22, marking an increase of 10.02.
• For NP After MI And SOA Margin (%), as of Mar 24, the value is -3.87. This value is below the healthy minimum of 8. It has increased from -12.36 (Mar 23) to -3.87, marking an increase of 8.49.
• For Return on Capital Employeed (%), as of Mar 24, the value is 113.58. This value is within the healthy range. It has increased from 35.91 (Mar 23) to 113.58, marking an increase of 77.67.
• For Return On Assets (%), as of Mar 24, the value is -1.07. This value is below the healthy minimum of 5. It has increased from -3.49 (Mar 23) to -1.07, marking an increase of 2.42.
• For Long Term Debt / Equity (X), as of Mar 24, the value is -1.05. This value is below the healthy minimum of 0.2. It has decreased from -0.86 (Mar 23) to -1.05, marking a decrease of 0.19.
• For Total Debt / Equity (X), as of Mar 24, the value is -2.54. This value is within the healthy range. It has decreased from -1.68 (Mar 23) to -2.54, marking a decrease of 0.86.
• For Asset Turnover Ratio (%), as of Mar 24, the value is 0.00. It has decreased from 0.24 (Mar 23) to 0.00, marking a decrease of 0.24.
• For Current Ratio (X), as of Mar 24, the value is 0.53. This value is below the healthy minimum of 1.5. It has decreased from 0.54 (Mar 23) to 0.53, marking a decrease of 0.01.
• For Quick Ratio (X), as of Mar 24, the value is 0.53. This value is below the healthy minimum of 1. It has decreased from 0.54 (Mar 23) to 0.53, marking a decrease of 0.01.
• For Inventory Turnover Ratio (X), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 4. It has decreased from 222.50 (Mar 23) to 0.00, marking a decrease of 222.50.
• For Interest Coverage Ratio (X), as of Mar 24, the value is 0.05. This value is below the healthy minimum of 3. It has decreased from 13.77 (Mar 23) to 0.05, marking a decrease of 13.72.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is -0.46. This value is below the healthy minimum of 3. It has increased from -2.76 (Mar 23) to -0.46, marking an increase of 2.30.
• For Enterprise Value (Cr.), as of Mar 24, the value is 3,357.31. It has increased from 2,724.44 (Mar 23) to 3,357.31, marking an increase of 632.87.
• For EV / Net Operating Revenue (X), as of Mar 24, the value is 2.88. This value is within the healthy range. It has increased from 2.34 (Mar 23) to 2.88, marking an increase of 0.54.
• For EV / EBITDA (X), as of Mar 24, the value is 1,412.95. This value exceeds the healthy maximum of 15. It has increased from 4.20 (Mar 23) to 1,412.95, marking an increase of 1,408.75.
• For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 0.05. This value is below the healthy minimum of 1. It has increased from 0.02 (Mar 23) to 0.05, marking an increase of 0.03.
• For Price / BV (X), as of Mar 24, the value is -0.04. This value is below the healthy minimum of 1. It has decreased from -0.01 (Mar 23) to -0.04, marking a decrease of 0.03.
• For Price / Net Operating Revenue (X), as of Mar 24, the value is 0.05. This value is below the healthy minimum of 1. It has increased from 0.02 (Mar 23) to 0.05, marking an increase of 0.03.
• For EarningsYield, as of Mar 24, the value is -0.66. This value is below the healthy minimum of 5. It has increased from -5.63 (Mar 23) to -0.66, marking an increase of 4.97.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness